VisionGate

VisionGate is dedicated to saving lives through early disease detection. VisionGate’s first commercial product, LuCED®, focuses on the #1 cancer killer – lung cancer. LuCED is a non-invasive test to aid physicians in the early detection of lung cancer utilizing sputum (phlegm). VisionGate’s LuCED test creates automated 3D images of cells in sputum, essentially taking a CT scan of individual cells. Once a 3D image is created, a smart computer program (algorithm) determines normal from abnormal cells, allowing for earlier disease detection. Although the CT scan has been around since 1970, this is the first time an individual cell has been able to be viewed in 3D – a capability of LuCED with more than 125 patents surrounding its development.

Company Growth (employees)
Type
Private
HQ
Phoenix, US
Founded
2001
Size (employees)
52 (est)-1%
VisionGate was founded in 2001 and is headquartered in Phoenix, US

Key People/Management at VisionGate

Alan Nelson

Alan Nelson

Founder, Chairman & CEO
Michael Meyer

Michael Meyer

Chief Technology Officer
Javier Zulueta

Javier Zulueta

Chief Medical Officer
Scarlett Spring

Scarlett Spring

President and Chief Commercial Officer

VisionGate Office Locations

VisionGate has an office in Phoenix
Phoenix, US (HQ)
2 10220 S 51st St
Phoenix, US
10220 S 51st St

VisionGate Financials and Metrics

Summary Metrics

Founding Date

2001

Total Funding

$10.5 m

Time since last funding

12 months

Investors

Traffic Overview of VisionGate

VisionGate Online and Social Media Presence

VisionGate Company Life and Culture

You may also be interested in